Eli Lilly Earnings Top, 2025 Guidance Strong, But Weight-Loss Drug Sales Miss
Eli Lilly earnings topped Q4 views with 2025 guidance above consensus, even though Zepbound and Mounjaro slightly missed. Eli Lilly stock rose.
Bristol Myers Earnings Are ‘a Tale of 2 Trends’ as Guidance Falls Short
The drugmaker Bristol Myers Squibb has been a standout among its big pharma peers over the past six months, scoring a ...
Hosted on MSN17h
One EV Truck Maker is Going to Zero, And It’s Just The First Domino To fall (RIVN, LCID, NKLA)
With shares under $1, Nikola (NASDAQ: NKLA) is risking bankruptcy, underscoring the larger difficulties smaller EV firms like Lucid (NASDAQ: LCID) and Rivian (NASDAQ: RIVN). While conventional ...